Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06152679
Status:
RECRUITING
Last Update Posted:
2023-12-01
First Post:
2023-11-21
Brief Title:
Day-case Endourology Patient Experience
Sponsor:
Royal Devon and Exeter NHS Foundation Trust
Organization:
Royal Devon and Exeter NHS Foundation Trust
Study Overview
Official Title:
Understanding the Patient Experience of Day-case Bladder Tumour Resection and Prostate Resection or Enucleation Qualitative Patient Interviews
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A qualitative research study interviewing patients treated in hospitals across England We will interview patients who have recently undergone one of the following operations as a day-case transurethral bladder tumour resection TURBT transurethral resection of prostate TURP or transurethral enucleation of the prostate TUEP We are interested to find out about the experience for patients who go home on the day of surgery after they have had one of these operations We hope that the findings will tell us about how to improve the experience for patients in future
Patients undergoing day-case surgery at a range of different hospitals from across England with varying day-case rates will be interviewed Hospitals in large city and more rural areas will be included Interviews are anticipated to take place over a six month period The study will end when saturation is achieved whereby no new themes are identified through interviews Saturation will be sought for each individual operation of interest
Patients undergoing day-case surgery at a range of different hospitals from across England with varying day-case rates will be interviewed Hospitals in large city and more rural areas will be included Interviews are anticipated to take place over a six month period The study will end when saturation is achieved whereby no new themes are identified through interviews Saturation will be sought for each individual operation of interest
Detailed Description:
Safe day-case surgery pathways offer to reduce pressure on hospitals by avoiding overnight inpatient admission This is particularly relevant given the intense pressures on hospital resources in the United Kingdom Urological surgery includes a number of frequently performed operations for which safe day-case surgery pathways have been demonstrated but for which day surgery is routine widespread routine practice These include bladder tumour resection TURBT and prostate resection or enucleation using diathermy or laser TURP and TUEP All of these operation types involve endoscopic access to the bladder via the urethra and do not involve skin incisions They can be performed under general or spinal anaesthesia
For 12 months from December 2021 the national average day-case rate for transurethral resection of bladder tumour In England was 211 and ranged from 0 to 873 at different hospitals with an interquartile range IQR of 105 to 377 and 23071 cases performed in total For bladder outflow obstruction surgery the median day-case rate was 77 range 0 to 824 IQR 44 to 191 18912 cases and this includes TURP and TUEP This demonstrates that for these common operations there is significant variation in practice across England
The Getting It Right First Time GIRFT Urology programme advocates for a day-case by default approach to TURBT and that day-case surgery should ideally be offered for prostate resection and enucleation As well as reducing pressure on inpatient services greater day-case adoption offers to reduce financial costs shorten waiting lists by allowing greater access to day-case theatres away from the acute hospital and reduce environmental impact by adopting a less resource-intensive approach It also offers a more standardised patient experience however we do not understand a great deal about the lived patient experience after discharge
National day-case rates for of TURBT and bladder outflow obstruction surgery using TURP or TUEP have increased over the past five years Many hospitals have well-established pathways whilst others are newly adopting this approach or not yet adopting day-case surgery for these operation types at all There is an opportunity to understand the patient experience of different day-case surgery pathways for these operations of interest so that we might understand factors contributing to a favourable or unfavourable experience This knowledge could inform future day-case pathway development and modification is a way that is more acceptable for patients
To explore this area we intend to perform qualitative research involving patients We will interview patients who were treated at a range of different hospitals with differing day-case performances
For 12 months from December 2021 the national average day-case rate for transurethral resection of bladder tumour In England was 211 and ranged from 0 to 873 at different hospitals with an interquartile range IQR of 105 to 377 and 23071 cases performed in total For bladder outflow obstruction surgery the median day-case rate was 77 range 0 to 824 IQR 44 to 191 18912 cases and this includes TURP and TUEP This demonstrates that for these common operations there is significant variation in practice across England
The Getting It Right First Time GIRFT Urology programme advocates for a day-case by default approach to TURBT and that day-case surgery should ideally be offered for prostate resection and enucleation As well as reducing pressure on inpatient services greater day-case adoption offers to reduce financial costs shorten waiting lists by allowing greater access to day-case theatres away from the acute hospital and reduce environmental impact by adopting a less resource-intensive approach It also offers a more standardised patient experience however we do not understand a great deal about the lived patient experience after discharge
National day-case rates for of TURBT and bladder outflow obstruction surgery using TURP or TUEP have increased over the past five years Many hospitals have well-established pathways whilst others are newly adopting this approach or not yet adopting day-case surgery for these operation types at all There is an opportunity to understand the patient experience of different day-case surgery pathways for these operations of interest so that we might understand factors contributing to a favourable or unfavourable experience This knowledge could inform future day-case pathway development and modification is a way that is more acceptable for patients
To explore this area we intend to perform qualitative research involving patients We will interview patients who were treated at a range of different hospitals with differing day-case performances
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None